Dorothy A Kieffer1,2,3, Brian D Piccolo4,5, Maria L Marco6, Eun Bae Kim6,7, Michael L Goodson8, Michael J Keenan9, Tamara N Dunn1,2,3, Knud Erik Bach Knudsen10, Roy J Martin11,2,3, Sean H Adams11,2,4,5. 1. Graduate Group in Nutritional Biology and. 2. Department of Nutrition. 3. Obesity and Metabolism Research Unit, USDA-Agricultural Research Service Western Human Nutrition Research Center, Davis, CA. 4. Arkansas Children's Nutrition Center and. 5. Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR. 6. Food Science and Technology Department, and. 7. Department of Animal Life Science, College of Animal Life Sciences, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea. 8. Department of Microbiology, University of California, Davis, CA. 9. Louisiana State University AgCenter, Baton Rouge, LA; and. 10. Department of Animal Science, Aarhus University, Aarhus, Denmark. 11. Graduate Group in Nutritional Biology and rmartin@agcenter.lsu.edu shadams@uams.edu.
Abstract
BACKGROUND: High-amylose-maize resistant starch type 2 (HAMRS2) is a fermentable dietary fiber known to alter the gut milieu, including the gut microbiota, which may explain the reported effects of resistant starch to ameliorate obesity-associated metabolic dysfunction. OBJECTIVE: Our working hypothesis was that HAMRS2-induced microbiome changes alter gut-derived signals (i.e., xenometabolites) reaching the liver via the portal circulation, in turn altering liver metabolism by regulating gene expression and other pathways. METHODS: We used a multi-omics systems biology approach to characterize HAMRS2-driven shifts to the cecal microbiome, liver metabolome, and transcriptome, identifying correlates between microbial changes and liver metabolites under obesogenic conditions that, to our knowledge, have not previously been recognized. Five-week-old male C57BL/6J mice were fed an energy-dense 45% lard-based-fat diet for 10 wk supplemented with either 20% HAMRS2 by weight (n = 14) or rapidly digestible starch (control diet; n = 15). RESULTS: Despite no differences in food intake, body weight, glucose tolerance, fasting plasma insulin, or liver triglycerides, the HAMRS2 mice showed a 15-58% reduction in all measured liver amino acids, except for Gln, compared with control mice. These metabolites were equivalent in the plasma of HAMRS2 mice compared with controls, and transcripts encoding key amino acid transporters were not different in the small intestine or liver, suggesting that HAMRS2 effects were not simply due to lower hepatocyte exposure to systemic amino acids. Instead, alterations in gut microbial metabolism could have affected host nitrogen and amino acid homeostasis: HAMRS2 mice showed a 62% increase (P < 0.0001) in 48-h fecal output and a 41% increase (P < 0.0001) in fecal nitrogen compared with control mice. Beyond amino acid metabolism, liver transcriptomics revealed pathways related to lipid and xenobiotic metabolism; and pathways related to cell proliferation, differentiation, and growth were affected by HAMRS2 feeding. CONCLUSION: Together, these differences indicate that HAMRS2 dramatically alters hepatic metabolism and gene expression concurrent with shifts in specific gut bacteria in C57BL/6J mice.
BACKGROUND: High-amylose-maize resistant starch type 2 (HAMRS2) is a fermentable dietary fiber known to alter the gut milieu, including the gut microbiota, which may explain the reported effects of resistant starch to ameliorate obesity-associated metabolic dysfunction. OBJECTIVE: Our working hypothesis was that HAMRS2-induced microbiome changes alter gut-derived signals (i.e., xenometabolites) reaching the liver via the portal circulation, in turn altering liver metabolism by regulating gene expression and other pathways. METHODS: We used a multi-omics systems biology approach to characterize HAMRS2-driven shifts to the cecal microbiome, liver metabolome, and transcriptome, identifying correlates between microbial changes and liver metabolites under obesogenic conditions that, to our knowledge, have not previously been recognized. Five-week-old male C57BL/6J mice were fed an energy-dense 45% lard-based-fat diet for 10 wk supplemented with either 20% HAMRS2 by weight (n = 14) or rapidly digestible starch (control diet; n = 15). RESULTS: Despite no differences in food intake, body weight, glucose tolerance, fasting plasma insulin, or liver triglycerides, the HAMRS2 mice showed a 15-58% reduction in all measured liver amino acids, except for Gln, compared with control mice. These metabolites were equivalent in the plasma of HAMRS2 mice compared with controls, and transcripts encoding key amino acid transporters were not different in the small intestine or liver, suggesting that HAMRS2 effects were not simply due to lower hepatocyte exposure to systemic amino acids. Instead, alterations in gut microbial metabolism could have affected host nitrogen and amino acid homeostasis: HAMRS2 mice showed a 62% increase (P < 0.0001) in 48-h fecal output and a 41% increase (P < 0.0001) in fecal nitrogen compared with control mice. Beyond amino acid metabolism, liver transcriptomics revealed pathways related to lipid and xenobiotic metabolism; and pathways related to cell proliferation, differentiation, and growth were affected by HAMRS2 feeding. CONCLUSION: Together, these differences indicate that HAMRS2 dramatically alters hepatic metabolism and gene expression concurrent with shifts in specific gut bacteria in C57BL/6J mice.
Authors: Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint Journal: ISME J Date: 2010-08-05 Impact factor: 10.302
Authors: Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland Journal: Nat Med Date: 2014-01-05 Impact factor: 53.440
Authors: Michael J Keenan; Roy J Martin; Anne M Raggio; Kathleen L McCutcheon; Ian L Brown; Anne Birkett; Susan S Newman; Jihad Skaf; Maren Hegsted; Richard T Tulley; Eric Blair; June Zhou Journal: J Nutrigenet Nutrigenomics Date: 2012-04-20
Authors: Nadja Larsen; Finn K Vogensen; Frans W J van den Berg; Dennis Sandris Nielsen; Anne Sofie Andreasen; Bente K Pedersen; Waleed Abu Al-Soud; Søren J Sørensen; Lars H Hansen; Mogens Jakobsen Journal: PLoS One Date: 2010-02-05 Impact factor: 3.240
Authors: Daniëlle Haenen; Carol Souza da Silva; Jing Zhang; Sietse Jan Koopmans; Guido Bosch; Jacques Vervoort; Walter J J Gerrits; Bas Kemp; Hauke Smidt; Michael Müller; Guido J E J Hooiveld Journal: J Nutr Date: 2013-10-16 Impact factor: 4.798
Authors: Michael J Keenan; Marlene Janes; Julina Robert; Roy J Martin; Anne M Raggio; Kathleen L McCutcheon; Christine Pelkman; Richard Tulley; M'Famara Goita; Holiday A Durham; June Zhou; Reshani N Senevirathne Journal: Obesity (Silver Spring) Date: 2013-05 Impact factor: 5.002
Authors: Jibran A Wali; Yen Chin Koay; Jason Chami; Courtney Wood; Leo Corcilius; Richard J Payne; Roman N Rodionov; Andreas L Birkenfeld; Dorit Samocha-Bonet; Stephen J Simpson; John F O'Sullivan Journal: Am J Physiol Endocrinol Metab Date: 2020-07-14 Impact factor: 4.310
Authors: Jibran A Wali; Annabelle J Milner; Alison W S Luk; Tamara J Pulpitel; Tim Dodgson; Harrison J W Facey; Devin Wahl; Melkam A Kebede; Alistair M Senior; Mitchell A Sullivan; Amanda E Brandon; Belinda Yau; Glen P Lockwood; Yen Chin Koay; Rosilene Ribeiro; Samantha M Solon-Biet; Kim S Bell-Anderson; John F O'Sullivan; Laurence Macia; Josephine M Forbes; Gregory J Cooney; Victoria C Cogger; Andrew Holmes; David Raubenheimer; David G Le Couteur; Stephen J Simpson Journal: Nat Metab Date: 2021-06-08
Authors: Kelly E Mercer; Laxmi Yeruva; Lindsay Pack; James L Graham; Kimber L Stanhope; Sree V Chintapalli; Umesh D Wankhade; Kartik Shankar; Peter J Havel; Sean H Adams; Brian D Piccolo Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-06-08 Impact factor: 4.052
Authors: Kelly E Mercer; Gabriella A M Ten Have; Lindsay Pack; Renny Lan; Nicolaas E P Deutz; Sean H Adams; Brian D Piccolo Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-06-15 Impact factor: 4.052